WO2021045237A1 - Corps d'emballage pour comprimés contenant de l'acide trichloro-isocyanurique - Google Patents

Corps d'emballage pour comprimés contenant de l'acide trichloro-isocyanurique Download PDF

Info

Publication number
WO2021045237A1
WO2021045237A1 PCT/JP2020/033842 JP2020033842W WO2021045237A1 WO 2021045237 A1 WO2021045237 A1 WO 2021045237A1 JP 2020033842 W JP2020033842 W JP 2020033842W WO 2021045237 A1 WO2021045237 A1 WO 2021045237A1
Authority
WO
WIPO (PCT)
Prior art keywords
layer
tcca
package
tablet
tablets
Prior art date
Application number
PCT/JP2020/033842
Other languages
English (en)
Japanese (ja)
Inventor
水野　昇
敬洋 霜田
Original Assignee
株式会社グリーンウェル
株式会社クリード
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2020147577A external-priority patent/JP2021041162A/ja
Application filed by 株式会社グリーンウェル, 株式会社クリード filed Critical 株式会社グリーンウェル
Publication of WO2021045237A1 publication Critical patent/WO2021045237A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/66—1,3,5-Triazines, not hydrogenated and not substituted at the ring nitrogen atoms
    • A01N43/68—1,3,5-Triazines, not hydrogenated and not substituted at the ring nitrogen atoms with two or three nitrogen atoms directly attached to ring carbon atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/32—Layered products comprising a layer of synthetic resin comprising polyolefins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/36—Layered products comprising a layer of synthetic resin comprising polyesters
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
    • B65D65/38—Packaging materials of special type or form
    • B65D65/40—Applications of laminates for particular packaging purposes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding

Definitions

  • the present invention is also referred to as a tablet containing trichloroisocyanuric acid (hereinafter, also referred to as "TCCA”), which is dissolved in water at the time of use and sprayed indoors to be used for sterilization and deodorization (hereinafter, also referred to as "TCCA-containing tablet”). ) Is related to the packaging body.
  • TCCA trichloroisocyanuric acid
  • hypochlorous acid water aqueous solution of hypochlorous acid
  • hypochlorous acid dissolved in water has been used. It has the disadvantage that sterilizing and deodorizing components such as chloric acid volatilize.
  • hypochlorous acid water is sold in bottles and packs, but since the sterilizing and deodorizing components such as hypochlorous acid volatilize, it is sold and used in a short period of time after it is manufactured. It is necessary and troublesome to handle.
  • Patent Document 1 states that a liquid having a bactericidal action and a deodorizing action is stored in a water storage unit, and this liquid is sprayed to remove the room.
  • Bacteria and deodorization are disclosed, and Patent Documents 2 and 3 contain electrolyzed water containing hypochlorous acid and active oxygen, which have bactericidal and deodorizing effects by electrolyzing water such as tap water. It is disclosed that the electrolyzed water is sprayed to sterilize and deodorize the room.
  • Patent Documents 4 and 5 disclose that TCCA-containing tablets are used as a cleaning agent for removing slime from a drain port.
  • Patent Document 1 it takes time and effort to prepare a special liquid having a bactericidal action and a deodorizing action, and when a commercially available hypochlorous acid water is used, the above-mentioned It becomes troublesome to handle. Further, in Patent Documents 2 and 3, since a device for electrolyzing water such as tap water is required, cost and labor are required. The use of TCCA-containing tablets as a cleaning agent has been conventionally practiced as disclosed in Patent Documents 4 and 5, but has not been used to obtain hypochlorous acid water. ..
  • Patent Document 6 Proposed a sterilization / deodorization system using TCCA-containing tablets (Patent Document 6) and further provided a blister package (Patent Document 7) in which a plurality of TCCA-containing tablets were packaged in a plastic package so as not to come into contact with each other.
  • Patent Document 7 Proposed a sterilization / deodorization system using TCCA-containing tablets (Patent Document 6) and further provided a blister package (Patent Document 7) in which a plurality of TCCA-containing tablets were packaged in a plastic package so as not to come into contact with each other.
  • a new problem with such packaging forms is the hydrolysis of TCCA itself due to moisture absorption, TCCA and alkali metal carbonates and / or bicarbonate alkalis that may be contained in TCCA tablets.
  • Chlorine gas is generated by the reaction with the metal, and even if a package containing a metal layer is used to improve the gas barrier property, the metal is corroded and deteriorated by the slightly generated chlorine gas, and the gas barrier property is improved. The problem arises of rapid decline.
  • TCCA-containing tablets decompose to generate chlorine during the storage / storage period (hereinafter, also referred to as “storage / storage period”) from the time they are manufactured / packaged to the time they are dissolved in water and used.
  • storage / storage period also referred to as “storage / storage period”
  • the present invention has been made by diligently studying a packaging capable of significantly reducing the decomposition of TCCA-containing tablets during the storage and storage period.
  • an object of the package of the TCCA-containing tablet of the present invention is to significantly reduce the decomposition of the TCCA-containing tablet during the storage and storage period.
  • TCCA-containing tablets a) A first layer composed of a polyethylene terephthalate layer, b) A third layer composed of an elastic resin layer laminated on the first layer, a second layer in which a metal layer and a polyethylene layer are arranged from the first layer side, and c) a second layer laminated on the second layer.
  • the first layer is sandwiched by two laminated films having layers so as to face each other.
  • the gist of the present invention is shown below.
  • (1) Tablets containing trichloroisocyanuric acid a) A first layer composed of a polyethylene terephthalate layer, b) A third layer composed of an elastic resin layer laminated on the first layer, a second layer in which a metal layer and a polyethylene layer are arranged from the first layer side, and c) a second layer laminated on the second layer.
  • the first layer is sandwiched by two laminated films having layers so as to face each other.
  • a package of tablets containing trichloroisocyanuric acid which is sealed by welding the two laminated films to each other.
  • the package of the TCCA-containing tablet of the present invention can significantly reduce the decomposition of the TCCA-containing tablet during the storage and storage period.
  • TCCA-containing tablets ⁇ Ingredients of TCCA-containing tablets> TCCA-containing tablets contain TCCA as the main component.
  • TCCA is a solid compound represented by the chemical formula of [Chemical formula 1], and when it is put into water, it releases active chlorine having a strong oxidizing ability similar to active oxygen, and makes water hypophilic. It can be chlorinated water.
  • Hypochlorite water has a high bactericidal action against viruses and fungi, and can inactivate viruses such as norovirus and influenza virus, and fungi such as Staphylococcus aureus, anthrax, and salmonella. ..
  • Hypochlorous acid is a very unstable substance and is known to gradually decompose in an aqueous solution, but TCCA has a solubility in water of about 1.2 g and a slow dissolution rate, so it can be dissolved in water. When charged, a low concentration of active halogen can be released over a long period of time.
  • Hypochlorite water can be obtained easily and economically by putting TCCA-containing tablets into water, and further, by spraying this hypochlorite water, each household, hospital, nursery school, etc.
  • the room can be easily and economically sterilized and deodorized.
  • the TCCA-containing tablet may contain the following additives in addition to TCCA.
  • bulking agents include alkali metal silicates, carbonates, bicarbonates, phosphates, sulfates, etc., in addition to sardines and salt.
  • sardine is particularly preferable because it can contain water as water of crystallization and is useful as a moisture barrier, and alkali metal carbonates and / or bicarbonates contribute to the hydrolysis of TCCA and hypochlorous acid. It is particularly preferable because it causes the occurrence of.
  • a binder or a lubricant can be contained in a proportion of about 0.1 to 5% by weight. By improving the moldability, it is possible to prevent the TCCA-containing tablet from being chipped or cracked, which occurs during the production or transportation of the TCCA-containing tablet.
  • the binder has a function of binding solid particles and is preferably water-soluble, but is not particularly limited.
  • the lubricant is not particularly limited as long as it has a function of improving the fluidity, filling property and adhesiveness of solid particles, and for example, calcium stearate, magnesium stearate, sodium stearate, sodium benzoate, orthoboric acid. , Talc, etc.
  • persulfate, percarbonate or perborate can be contained as a foaming agent or a disintegrant.
  • the foaming agent is composed of a combination of an acidic substance and an alkaline substance, and when the TCCA-containing tablet is put into water, both react to generate gas, so that the disintegration property of the TCCA-containing tablet can be enhanced.
  • acidic substances include organic acids such as citric acid, tartaric acid, oxalic acid, succinic acid, maleic acid, phthalic acid, malic acid and adipic acid, sodium dihydrogen phosphate, potassium dihydrogen phosphate and ammonium dihydrogen phosphate.
  • Hydrogen salts such as potassium hydrogen sulfate, and myobans such as carimyoban and ammonium myoban.
  • alkaline substance include carbonates such as sodium carbonate, potassium carbonate, calcium carbonate, magnesium carbonate and ammonium carbonate, and bicarbonates such as sodium bicarbonate and potassium bicarbonate.
  • the disintegrant can absorb water and swell when the TCCA-containing tablet is put into water, or generate carbon dioxide gas and foam to disintegrate the TCCA-containing tablet.
  • carboxymethyl cellulose calcium, crosslinked polyvinylpyrrolidone, and low degree of substitution. Hydroxypropyl cellulose and the like can be mentioned.
  • the starch described above also functions as a binder, but also has a function as a disintegrant.
  • TCCA-containing tablet in order to color or perfume the TCCA-containing tablet, conventionally known dyes, pigments or fragrances can be contained in the TCCA-containing tablet.
  • a layer containing a dye, pigment or fragrance together with a bulking agent (excipient) is provided. It may be provided separately.
  • TCCA-containing tablets are produced by a method of filling a mold with a raw material such as powder or granules of TCCA and pressurizing the mold (hereinafter, also referred to as "tablet").
  • a known pressure-type locking machine composed of a mold (usuki) and a pressurizing device is preferably used.
  • the raw materials are sequentially charged into the mortar and pressure is applied between the mortar and the pestle via a pressurizing device, the raw materials are crimped to produce a TCCA-containing tablet having a shape formed by the mortar and the pestle. Will be done.
  • a single-shot tableting machine that locks one tablet at a time and a plurality of dies (molds) are mounted along a rotating disk, and the raw material is used during one rotation.
  • a rotary tableting machine capable of continuously performing a series of operations such as filling, pressure molding, and taking out TCCA-containing tablets can be used.
  • single-shot lockers include RIVA's "MINIPRESSM II” and "PICCOLA”, Kikusui Seisakusho's rigid powder molding machine, Okada Seiko's single-shot locker, and Fuji Yakuhin Kikai's standing press. Can be mentioned.
  • rotary lockers examples include “Rotary Press TRP Series” manufactured by Mori Machinery Co., Ltd., “Clean Press Series” manufactured by Kikusui Seisakusho Co., Ltd., “Tough Press Series”, “P Series” manufactured by FETTE Co., Ltd., and “P Series”. Examples include “PT series”, “PH series” manufactured by KORSCH, and “B series” manufactured by Hata Iron Works.
  • Hypochlorous acid water is strongly acidic hypochlorous acid water (pH 2.7 or less, effective chlorine concentration 20 to 60 ppm), weakly acidic hypochlorous acid water (pH 2.7 to 5.0, effective chlorine concentration 10 to 60 ppm). ), Slightly acidic hypochlorous acid water (pH 5.0 to 6.5, effective chlorine concentration 10 to 80 ppm), but the slightly acidic hypochlorous acid water has the same pH value as human skin. Because of the degree, it has a feature of being excellent in safety while having a high bactericidal action. In addition, it has the feature that the chlorine odor peculiar to chlorine-based bactericides does not remain.
  • the weight of the TCCA-containing tablet is not particularly limited, but the range in which the water that fills the water tank of the device such as a spray, a spray device, a humidifier, etc. that sprays hypochlorite water can be made into slightly acidic hypochlorite water. It is preferable from the viewpoint of ease of use.
  • a slightly acidic hypochloroisocyanuric acid water can be obtained by a simple operation of filling a water tank with water and putting one TCCA-containing tablet into the water tank.
  • the pH is 5.5. Since slightly acidic hypochlorite water of up to 6.9 (depending on the alkalinity of tap water) can be obtained, the weight of the TCCA-containing tablet is preferably 0.3 to 1.0 g.
  • the shape of the TCCA-containing tablet is not particularly limited, and the shape can be appropriately determined from the viewpoint of ease of tableting, ease of handling, and ease of use.
  • Examples of the shape of the TCCA-containing tablet include a cylindrical shape, a cubic shape, a rectangular parallelepiped shape, and the like, but from the above viewpoint, the cylindrical shape is preferable.
  • the diameter is 5 to 15 mm and the height is 2 to 6 mm.
  • the laminated film (4) having the above is used.
  • the TCCA-containing tablet (5) is sandwiched by the two laminated films (4) from above and below so that the first layer (1) faces each other.
  • the two laminated films (4) that sandwich the TCCA-containing tablet (5) from above and below two separate laminated films may be used, or one laminated film may be folded back and used.
  • a metal film is also used in the packaging of ordinary tablets in order to improve the gas barrier property.
  • A is composed of an Aa layer made of a polyethylene terephthalate layer having excellent chemical resistance, heat welding resistance, etc., and an Ab layer made of a metal layer provided on the polyethylene terephthalate layer.
  • a laminated film having a layer and a layer B composed of an elastic resin layer that protects the metal layer Ab is used.
  • the TCCA-containing tablet of the present invention is hydrolyzed with a small amount of water to generate hypochlorous acid, which is decomposed into hydrogen chloride and free oxygen and corrodes the metal layer. Decomposition of TCCA is promoted during the storage / storage period.
  • the polyethylene layer (2-1) of the second layer (2) in addition to the third layer (3) corresponding to the B layer, moisture permeates from the outside of the package and hydrogen chloride from the TCCA-containing tablet. Permeation can be significantly suppressed, and decomposition of TCCA-containing tablets during the storage and storage period can be significantly reduced.
  • Example 1 As shown in Example 1 and Comparative Example 1 described later, surprisingly, by using a polyethylene layer (2-1) having a metal layer (2-2) as the second layer (2), Decomposition of TCCA-containing tablets during the storage / storage period can be significantly reduced.
  • the package of the TCCA-containing tablet of the present invention is formed by sandwiching the TCCA-containing tablet from above and below with two laminated films so that the first layer faces each other, and sealing by welding the two laminated films.
  • a laminated film (4) that has not been shaped in advance may be used as in the first embodiment shown in [FIG. 2], or TCCA as in the second embodiment shown in [FIG. 3].
  • a laminated film (4) in which a portion corresponding to the accommodating portion of the contained tablet (5) is formed in a concave shape in advance may be used.
  • TCCA-containing tablet of the present invention it is preferable that a plurality of TCCA-containing tablets are individually sealed by welding of a laminated film.
  • the TCCA-containing tablet used in the packaging of the TCCA-containing tablet of the present invention contains anhydrous sodium sulfate.
  • anhydrous sodium sulfate By containing anhydrous sodium sulfate in the TCCA-containing tablet, even if some water such as water vapor invades the sealed portion of the TCCA-containing tablet, the water can be fixed as water of crystallization by the anhydrous sodium sulfate, and decomposition of the TCCA-containing tablet is avoided. it can.
  • the first layer (1) of the laminated film (4) is a basic material of the package of the present invention, and is mechanically and physically. It is formed using a polyethylene terephthalate layer (1-1) having excellent chemical properties.
  • the polyethylene terephthalate layer (1-1) either an unstretched film or a stretched film stretched in the uniaxial direction or the biaxial direction can be used, but from the viewpoint of mechanical strength, the stretched film stretched in the biaxial direction can be used. It is preferable to use a film.
  • the thickness of the polyethylene terephthalate layer (1-1) is preferably 5 to 25 ⁇ m, more preferably 10 to 20 ⁇ m.
  • the thickness of the polyethylene terephthalate layer (1-1) is 5 ⁇ m or more, the permeation of water from the outside of the package and the permeation of hydrogen chloride from the TCCA-containing tablet can be reduced, and when it is 25 ⁇ m or less, the laminated film. Can be preferably welded.
  • the second layer (2) of the laminated film (4) reduces the permeation of water from the outside of the package and the permeation of hydrogen chloride from the TCCA-containing tablet (5).
  • a metal layer (2-2) and a polyethylene layer (2-1) are arranged from the first layer (1) side.
  • a metal layer (2-2) and a polyethylene layer (2-1) are arranged from the first layer (1) side as an intermediate layer of the laminated film (4). It is possible to significantly suppress the permeation of water from the outside of the package and the permeation of hydrogen chloride from the TCCA-containing tablet, and significantly reduce the decomposition of the TCCA-containing tablet during the storage / storage period.
  • a known method such as extrusion lamination or vapor deposition can be appropriately used.
  • Examples of the metal used for the metal layer (2-2) include aluminum, silicon oxide, aluminum oxide, indium oxide, tin oxide, and zirconium oxide, but aluminum is preferable from the viewpoint of gas barrier property, corrosion resistance, versatility, and the like. ..
  • the thickness of the metal layer (2-2) is preferably 1 to 20 ⁇ m, more preferably 5 to 10 ⁇ m. When the thickness of the metal layer (2-2) is 5 ⁇ m or more, the permeation of water from the outside of the package and the permeation of hydrogen chloride from the TCCA-containing tablet can be sufficiently reduced, and when the thickness is 20 ⁇ m or less, the strength becomes high. Sufficient moldability can be obtained without too much.
  • polyethylene layer (2-1) either an unstretched film or a stretched film stretched in a uniaxial direction or a biaxial direction can be used, but from the viewpoint of mechanical strength, a stretched film stretched in the biaxial direction. Is preferably used.
  • the thickness of the polyethylene layer (2-1) is preferably 5 to 25 ⁇ m, more preferably 10 to 20 ⁇ m. By setting the thickness of the polyethylene layer (2-1) to 5 to 25 ⁇ m, the metal layer (2-2) can be uniformly provided.
  • the third layer (3) of the laminated film (4) is formed by using an elastic resin layer (3-1) to protect the second layer (2). Will be done.
  • the resin used for the elastic resin layer (3-1) a resin having elasticity such as polypropylene, acrylic resin, ionomer resin and the like can be used, but polypropylene having excellent hardness and elasticity is preferable.
  • the thickness of the elastic resin layer (3-1) may be any as long as it can properly fix and protect the metal layer (2-2), and varies depending on the resin used, but is generally preferably 20 to 50 ⁇ m. ..
  • TCCA-containing tablets Using the above TCCA-containing tablets, a package of TCCA-containing tablets was prepared as in Examples 1 and 2 and Comparative Examples 1 and 2 below, and the following ⁇ stability test> was performed.
  • Example 1 The following ⁇ first layer> to ⁇ third layer> were laminated and pressure-bonded to prepare a laminated film.
  • First layer> Polyethylene terephthalate layer (15 ⁇ m)
  • ⁇ Second layer> An aluminum layer (8 ⁇ m) and a polyethylene layer (15 ⁇ m) laminated on the first layer from the first layer side.
  • ⁇ Third layer> A polypropylene layer (25 ⁇ m) laminated on the second layer.
  • the laminated film is folded in half with the ⁇ first layer> on the inside, the TCCA-containing tablet is placed inside the folded film, the three sides in the open state are thermocompression-bonded, and the outside of the seam is cut out to cut out the TCCA-containing tablet of Example 1.
  • a package of trichloroisocyanuric acid tablets was prepared.
  • the laminated film is folded in half with the ⁇ first layer> on the inside, the TCCA-containing tablet is placed inside the folded film, the three sides in the open state are thermocompression-bonded, and the outside of the seam is cut out to cut out the TCCA-containing tablet of Comparative Example 1.
  • a package of trichloroisocyanuric acid tablets was prepared.
  • Example 2 In the packaging of Example 1, the TCCA-containing tablet of Example 2 was the same as in Example 1 except that the polypropylene layer (25 ⁇ m) of the ⁇ third layer> was changed to a layer (30 ⁇ m) formed of an ionomer resin. Ionomer packaging was created.
  • Example 1 and Example 2 judged to be stable in the above ⁇ stability test> were dissolved in 5 L of tap water, they were immediately dissolved and the pH was 6.5.
  • the concentration of hypochlorous acid was 200 ppm.
  • the packaging of the TCCA-containing tablet of the present invention can significantly reduce the decomposition of the TCCA-containing tablet during the storage and storage period of the TCCA-containing tablet, and can stably reduce the decomposition of the TCCA-containing tablet at a predetermined concentration anytime and anywhere. It can be seen that ionized hypochlorous acid can be obtained.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Mechanical Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Toxicology (AREA)
  • Packages (AREA)

Abstract

La présente invention aborde le problème, dans un corps d'emballage pour un comprimé contenant du TCCA, consistant à réduire considérablement la décomposition du comprimé contenant du TCCA pendant une période de conservation/stockage.　Un comprimé contenant du TCCA est pris en sandwich entre deux films stratifiés ayant chacun (a) une première couche formée à partir d'une couche de téréphtalate de polyéthylène, (b) une deuxième couche qui est stratifiée sur la première couche et est telle qu'une couche métallique et une couche de polyéthylène sont disposées dans l'ordre à partir du côté première couche, et (c) une troisième couche qui est stratifiée sur la deuxième couche et est formée à partir d'une couche de résine élastique, le comprimé contenant du TCCA étant pris en sandwich de telle sorte que les premières couches se fassent face et étant emballé par scellement des deux films stratifiés par soudage, ce qui permet de réduire considérablement la décomposition du comprimé contenant du TCCA pendant une période de conservation/stockage.
PCT/JP2020/033842 2019-09-06 2020-09-07 Corps d'emballage pour comprimés contenant de l'acide trichloro-isocyanurique WO2021045237A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019174754 2019-09-06
JP2019-174754 2019-09-06
JP2020147577A JP2021041162A (ja) 2019-09-06 2020-09-02 トリクロロイソシアヌル酸を含有する錠剤の包装体
JP2020-147577 2020-09-02

Publications (1)

Publication Number Publication Date
WO2021045237A1 true WO2021045237A1 (fr) 2021-03-11

Family

ID=74852367

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/033842 WO2021045237A1 (fr) 2019-09-06 2020-09-07 Corps d'emballage pour comprimés contenant de l'acide trichloro-isocyanurique

Country Status (1)

Country Link
WO (1) WO2021045237A1 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762271A (en) * 1980-10-03 1982-04-15 Nissan Chem Ind Ltd Storing method of chlorinated isocyanuric acid or salt thereof
JPH0653464U (ja) * 1992-12-28 1994-07-22 恵徳株式会社 錠剤の封入袋体
JPH08151069A (ja) * 1994-11-29 1996-06-11 Idemitsu Petrochem Co Ltd 包装体
JPH10212209A (ja) * 1997-01-30 1998-08-11 Johnson Co Ltd 殺菌清浄剤
JP2002119575A (ja) * 2000-10-16 2002-04-23 Pigeon Corp ハロゲンガス遊離性薬剤の包装袋および包装ハロゲンガス遊離性薬剤
JP2006010924A (ja) * 2004-06-24 2006-01-12 Konica Minolta Photo Imaging Inc ハロゲン化銀カラー写真感光材料処理用固体処理剤及びそれを用いたハロゲン化銀カラー写真感光材料の処理方法
US20110103720A1 (en) * 2008-05-29 2011-05-05 Hydrus B.V. Method of manufacturing a bag and a bag
JP2017081113A (ja) * 2015-10-30 2017-05-18 藤森工業株式会社 包装袋用積層体およびその製造方法、包装袋およびその製造方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762271A (en) * 1980-10-03 1982-04-15 Nissan Chem Ind Ltd Storing method of chlorinated isocyanuric acid or salt thereof
JPH0653464U (ja) * 1992-12-28 1994-07-22 恵徳株式会社 錠剤の封入袋体
JPH08151069A (ja) * 1994-11-29 1996-06-11 Idemitsu Petrochem Co Ltd 包装体
JPH10212209A (ja) * 1997-01-30 1998-08-11 Johnson Co Ltd 殺菌清浄剤
JP2002119575A (ja) * 2000-10-16 2002-04-23 Pigeon Corp ハロゲンガス遊離性薬剤の包装袋および包装ハロゲンガス遊離性薬剤
JP2006010924A (ja) * 2004-06-24 2006-01-12 Konica Minolta Photo Imaging Inc ハロゲン化銀カラー写真感光材料処理用固体処理剤及びそれを用いたハロゲン化銀カラー写真感光材料の処理方法
US20110103720A1 (en) * 2008-05-29 2011-05-05 Hydrus B.V. Method of manufacturing a bag and a bag
JP2017081113A (ja) * 2015-10-30 2017-05-18 藤森工業株式会社 包装袋用積層体およびその製造方法、包装袋およびその製造方法

Similar Documents

Publication Publication Date Title
EP2130794B1 (fr) Solution pure de dioxyde de chlore, et composition de type gel et composition moussante comprenant chacune cette solution
US8262929B2 (en) Massive bodies containing free halogen source for producing highly converted solutions of chlorine dioxide
USRE36064E (en) Disinfection method and composition therefor
US5185161A (en) Disinfection method and composition therefor
EP3094177B1 (fr) Composition désinfectante ou assainissante sporocide
US11772968B2 (en) Multi-chamber hypochlorous acid dispenser
KR20190084395A (ko) 서방형 이산화염소 발생제형 및 이를 이용한 서방형 이산화염소 발생팩
JP5662244B2 (ja) 二酸化塩素ガス発生剤パックならびにその製造方法および保存方法
WO2005037327A2 (fr) Gel de dioxyde de chlore et procedes associes
JP2012036072A (ja) 用時二酸化塩素発生剤の製品形状ならびに成分組成
CN106900707A (zh) 一种含有过氧化物的消毒灭菌剂
GB2437489A (en) Disinfectant mixture of a donor of freely available chlorine (e.g. hypochlorite) and a buffering agent or acid, optionally in the form of an aqueous solution
WO2021045237A1 (fr) Corps d'emballage pour comprimés contenant de l'acide trichloro-isocyanurique
CN106689194A (zh) 一种缓释消毒水
JP2021041162A (ja) トリクロロイソシアヌル酸を含有する錠剤の包装体
CN101143225A (zh) 空气净化剂及其制备方法
JP6550570B2 (ja) 固形薬剤を封入した薬液噴霧装置
JP2019156784A (ja) 次亜塩素酸水を得るためのタブレットおよび該タブレットを包装したブリスター包装品
US11485638B2 (en) Multi-chamber hypochlorous acid dispenser
CN212127510U (zh) 一种可控制二氧化氯出气量的消毒剂发生器
US7651628B2 (en) Compression molded product of effervescent chlorinated isocyanuric acid
CN113812419A (zh) 一种二氧化氯泡腾消毒锭片
KR20220012774A (ko) 이산화염소 가스 방출용 고체형 조성물 및 이를 이용한 살균·탈취제
WO2005000368A1 (fr) Desodorisants desinfectants, solutions de desodorisant desinfectant, et procede de desinfection et de desodorisation les utilisant
WO2020120193A1 (fr) Système de désinfection

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20860050

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20860050

Country of ref document: EP

Kind code of ref document: A1